ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
NCT04912505
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Purpura, Thrombocytopenic
Interventions
DRUG:
Aspirin
Sponsor
University Hospital, Toulouse